Stout served as the exclusive financial advisor to Nuvectra Corp., a public medical products company, in connection with the sale of its assets to Cirtec Medical pursuant to Section 363 of the U.S. Bankruptcy Code. 

Nuvectra, headquartered in Plano, TX, was a medical device company that operated as a platform for the treatment of various disorders in neuroscience and clinical markets, and developed and sold neurostimulation products to treat a variety of conditions. After filing for Chapter 11 bankruptcy in the Eastern District of Texas, the Debtor retained Stout to run the sales process for Nuvectra.